Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This dose response study is proposed to explore the extent to which Nexium increases
endogenous gastrin concentrations and to assess whether Nexium treatment may be useful in the
setting of islet cell transplantation for type 1 diabetes to expand islet cells in vivo after
transplant.